This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

MobileMedMinder: A Networked Aide for Medication Compliances

This study has been completed.
Information provided by (Responsible Party):
Steve Gottlieb, University of Maryland Identifier:
First received: May 10, 2012
Last updated: December 9, 2013
Last verified: December 2013
The main aim of this study is to conduct a randomized control trial to compare MobileMedMinder, a mobile phone based medication reminder software product, with currently accepted and empirically supported methods for increasing medication compliance through reminders and tracking.

Condition Intervention
Heart Failure, Congestive Behavioral: Use of MobileMedMinder

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: MobileMedMinder: A Networked Aide for Medication Compliances

Further study details as provided by Steve Gottlieb, University of Maryland:

Primary Outcome Measures:
  • Compliance [ Time Frame: 3 months ]
    Pill counts will be used to assess compliance

Estimated Enrollment: 50
Study Start Date: November 2011
Study Completion Date: December 2013
Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Use of MobileMedMinder Behavioral: Use of MobileMedMinder
Use of an intervention to remind patients to take their medications.
No Intervention: Usual care


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Taking beta blockers, ACE or ARB, and hydralazine for treatment of HF.

Exclusion Criteria:

  • Inability to understand informed consent
  • Inability to read and understand English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01597583

United States, Maryland
University of Maryland
Baltimore, Maryland, United States, 21201
Sponsors and Collaborators
University of Maryland
  More Information

Responsible Party: Steve Gottlieb, Professor, University of Maryland Identifier: NCT01597583     History of Changes
Other Study ID Numbers: HP-00051021
Study First Received: May 10, 2012
Last Updated: December 9, 2013

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases processed this record on August 17, 2017